Fundz

Xaira Therapeutics raised a massive $1B in funding led by ARCH Venture Partners and Foresite Labs for AI drug discovery

PRIVATEApr 25, 2024

Amount Raised

$1 Billion

Round Type

Funding Round

BrisbaneBiotechnologyArtificial IntelligenceTherapeuticsMachine Learning

Investors

New Enterprise AssociatesSV AngelTwo Sigma VenturesMenlo VenturesLightspeed Venture PartnersLux CapitalSequoia CapitalF PrimeForesite LabsARCH Venture Partners

Description

Xaira Therapeutics, a startup specializing in AI drug discovery, has launched with a significant $1 billion funding round. The company aims to leverage recent AI breakthroughs to develop previously unattainable drugs.

Quick answer

Xaira Therapeutics raised $1 Billion in a Funding Round round, dated April 25, 2024. Investors: New Enterprise Associates, SV Angel, Two Sigma Ventures, Menlo Ventures, Lightspeed Venture Partners, Lux Capital, Sequoia Capital and F Prime. Xaira Therapeutics is based in Brisbane, California, United States.

How much did Xaira Therapeutics raise?
Xaira Therapeutics raised $1 Billion in a Funding Round round on April 25, 2024.
Who invested in Xaira Therapeutics?
New Enterprise Associates, SV Angel, Two Sigma Ventures, Menlo Ventures, Lightspeed Venture Partners, Lux Capital, Sequoia Capital and F Prime are named as investors in this round.
What does Xaira Therapeutics do?
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease.
Where is Xaira Therapeutics based and how big is it?
Xaira Therapeutics is based in Brisbane, California, United States. Fundz records about 164 employees.
Who are the decision-makers at Xaira Therapeutics?
Fundz holds 1 contact at Xaira Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Xaira Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Grove AI raised $4.9M (Seed) on May 14, 2024.
  • Yoneda Labs raised $4M (Seed) on April 26, 2024.
  • Corvex Legacy Holdings raised $24M on April 2, 2024.
  • NobleAI raised $10M (Series A) on April 2, 2024.
  • Corvex Legacy Holdings raised $24M (Seed) on April 2, 2024.
  • Manifest Technologies raised an undisclosed amount (Funding Round) on March 28, 2024.

Who to call at Xaira Therapeutics, and when

A new round usually means Xaira Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xaira Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xaira Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xaira Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xaira Therapeutics

Location

Brisbane, California, United States

About

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xaira Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Xaira Therapeutics's next move

See what Strategic adds

Xaira Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.